1-2 of 2
Raj S. Pruthi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

Carissa E. Chu, Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu, Vadim S. Koshkin, Bradley A. Stohr, Maxwell V. Meng, Raj S. Pruthi, Terence W. Friedlander, Yair Lotan, Peter C. Black, Sima P. Porten, Felix Y. Feng, Jonathan Chou
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (18): 5123–5130.
https://doi.org/10.1158/1078-0432.CCR-20-4175
Published: 15 September 2021
View article titled, Heterogeneity in <em>NECTIN4</em> Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin
Open the PDF for Heterogeneity in <em>NECTIN4</em> Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin in another window
Includes: Supplementary data
Journal Articles

Phase II Trial of Celecoxib in Prostate-Specific Antigen Recurrent Prostate Cancer after Definitive Radiation Therapy or Radical Prostatectomy

Raj S. Pruthi, J. Eric Derksen, Dominic Moore, Culley C. Carson, Gayle Grigson, Cathy Watkins, Eric Wallen
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (7): 2172–2177.
https://doi.org/10.1158/1078-0432.CCR-05-2067
Published: 11 April 2006
View article titled, Phase II Trial of Celecoxib in Prostate-Specific Antigen Recurrent Prostate Cancer after Definitive Radiation Therapy or Radical Prostatectomy
Open the PDF for Phase II Trial of Celecoxib in Prostate-Specific Antigen Recurrent Prostate Cancer after Definitive Radiation Therapy or Radical Prostatectomy in another window